Valued Wealth Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.28K Hold
5
﹤0.01% 741
2026
Q1
$1.22K Sell
5
-1
-17% -$271 ﹤0.01% 612
2025
Q4
$1.53K Hold
6
﹤0.01% 422
2025
Q3
$1.75K Hold
6
﹤0.01% 392
2025
Q2
$1.59K Hold
6
﹤0.01% 400
2025
Q1
$1.41K Hold
6
﹤0.01% 445
2024
Q4
$1.39K Buy
6
+2
+50% +$459 ﹤0.01% 438
2024
Q3
$903 Buy
4
+2
+100% +$440 ﹤0.01% 469
2024
Q2
$416 Hold
2
﹤0.01% 514
2024
Q1
$446 Hold
2
﹤0.01% 505
2023
Q4
$409 Buy
+2
New +$420 ﹤0.01% 447

Other funds holding LH

Valued Wealth Advisors's LH Position: Q2 2026 in Review

Valued Wealth Advisors held its Labcorp (LH) position steady in Q2 2026 at 5 shares worth $1.28K. The position accounts for ﹤0.01% of the portfolio, ranked #741.

Valued Wealth Advisors first reported a position in LH in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.75K in Q3 2025. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Valued Wealth Advisors held 5 shares of Labcorp worth $1.28K as of Q2 2026.
  • Valued Wealth Advisors left its Labcorp share count unchanged in Q2 2026.
  • Labcorp made up ﹤0.01% of Valued Wealth Advisors's portfolio in Q2 2026, its #741 holding.
  • Valued Wealth Advisors first reported a position in Labcorp in Q4 2023 and has held it in 11 quarters since.
  • Valued Wealth Advisors's Labcorp position peaked at $1.75K in Q3 2025.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Valued Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.